APO Research
Talk to an analyst

APO RESEARCH · REPORT

Software as a Medical Device (SaMD)

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

Selected research

Market Outlook & Growth Opportunities

Global Software as a Medical Device (SaMD) Market Outlook and Growth Opportunities 2026

28 December 2025190 pages

Choose your research edition.

Industry ResearchSoftware as a Medical Device (SaMD) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Software as a Medical Device (SaMD) Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Software as a Medical Device (SaMD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Software as a Medical Device (SaMD) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Software as a Medical Device (SaMD) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

According to types, the most proportion of the Global Software as a Medical Device market share is Cloud-based, taking about 67.34% share of global market in 2020. The most proportion of the Global Software as a Medical Device market share is used for Monitoring and Alerting and the proportion is about 41.55% in 2020.

This report provides an overview of the global Software as a Medical Device (SaMD) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Software as a Medical Device (SaMD) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Software as a Medical Device (SaMD) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Software as a Medical Device (SaMD) market.

Software as a Medical Device (SaMD) Segment by Company

MindMaze

Medtronic

Viz.AI.

Siemens Healthcare

iSchemaView

Arterys

Adherium

Digital Diagnostics

Allscripts

Software as a Medical Device (SaMD) Segment by Type

Cloud-based

On Premise

Software as a Medical Device (SaMD) Segment by Application

Screening and Diagnosis

Monitoring and Alerting

Chronic Disease Management

Other

Software as a Medical Device (SaMD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Software as a Medical Device (SaMD) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Software as a Medical Device (SaMD) key companies, revenue, market share, and recent developments.

3. To split the Software as a Medical Device (SaMD) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Software as a Medical Device (SaMD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Software as a Medical Device (SaMD) significant trends, drivers, influence factors in global and regions.

6. To analyze Software as a Medical Device (SaMD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Software as a Medical Device (SaMD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Software as a Medical Device (SaMD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Software as a Medical Device (SaMD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Software as a Medical Device (SaMD) industry.

Chapter 3: Detailed analysis of Software as a Medical Device (SaMD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Software as a Medical Device (SaMD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Software as a Medical Device (SaMD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Software as a Medical Device (SaMD) Industry Trends Table 2. Software as a Medical Device (SaMD) Industry Drivers Table 3. Software as a Medical Device (SaMD) Industry Opportunities and Challenges Table 4. Software as a Medical Device (SaMD) Industry Restraints Table 5. Global Software as a Medical Device (SaMD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Software as a Medical Device (SaMD) Revenue Share by Company (2021-2026) Table 7. Global Software as a Medical Device (SaMD) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Software as a Medical Device (SaMD) Key Company Manufacturing Base & Headquarters Table 9. Global Software as a Medical Device (SaMD) Company, Product Type & Application Table 10. Global Software as a Medical Device (SaMD) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Software as a Medical Device (SaMD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On Premise Table 16. Global Software as a Medical Device (SaMD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Software as a Medical Device (SaMD) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Software as a Medical Device (SaMD) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Software as a Medical Device (SaMD) Sales Value Share by Type (2021-2026) Table 20. Global Software as a Medical Device (SaMD) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Screening and Diagnosis Table 22. Significant Companies of Monitoring and Alerting Table 23. Significant Companies of Chronic Disease Management Table 24. Significant Companies of Other Table 25. Global Software as a Medical Device (SaMD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Software as a Medical Device (SaMD) Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Software as a Medical Device (SaMD) Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Software as a Medical Device (SaMD) Sales Value Share by Application (2021-2026) Table 29. Global Software as a Medical Device (SaMD) Sales Value Share by Application (2027-2032) Table 30. Global Software as a Medical Device (SaMD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Software as a Medical Device (SaMD) Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Software as a Medical Device (SaMD) Sales Value Share by Region (2021-2026) Table 33. Global Software as a Medical Device (SaMD) Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Software as a Medical Device (SaMD) Sales Value Share by Region (2027-2032) Table 35. Global Software as a Medical Device (SaMD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Software as a Medical Device (SaMD) Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Software as a Medical Device (SaMD) Sales Value Market Share by Country (2021-2026) Table 38. Global Software as a Medical Device (SaMD) Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Software as a Medical Device (SaMD) Sales Value Market Share by Country (2027-2032) Table 40. MindMaze Company Information Table 41. MindMaze Business Overview Table 42. MindMaze Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. MindMaze Software as a Medical Device (SaMD) Product Portfolio Table 44. MindMaze Recent Development Table 45. Medtronic Company Information Table 46. Medtronic Business Overview Table 47. Medtronic Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Medtronic Software as a Medical Device (SaMD) Product Portfolio Table 49. Medtronic Recent Development Table 50. Viz.AI. Company Information Table 51. Viz.AI. Business Overview Table 52. Viz.AI. Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Viz.AI. Software as a Medical Device (SaMD) Product Portfolio Table 54. Viz.AI. Recent Development Table 55. Siemens Healthcare Company Information Table 56. Siemens Healthcare Business Overview Table 57. Siemens Healthcare Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Siemens Healthcare Software as a Medical Device (SaMD) Product Portfolio Table 59. Siemens Healthcare Recent Development Table 60. iSchemaView Company Information Table 61. iSchemaView Business Overview Table 62. iSchemaView Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. iSchemaView Software as a Medical Device (SaMD) Product Portfolio Table 64. iSchemaView Recent Development Table 65. Arterys Company Information Table 66. Arterys Business Overview Table 67. Arterys Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Arterys Software as a Medical Device (SaMD) Product Portfolio Table 69. Arterys Recent Development Table 70. Adherium Company Information Table 71. Adherium Business Overview Table 72. Adherium Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Adherium Software as a Medical Device (SaMD) Product Portfolio Table 74. Adherium Recent Development Table 75. Digital Diagnostics Company Information Table 76. Digital Diagnostics Business Overview Table 77. Digital Diagnostics Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Digital Diagnostics Software as a Medical Device (SaMD) Product Portfolio Table 79. Digital Diagnostics Recent Development Table 80. Allscripts Company Information Table 81. Allscripts Business Overview Table 82. Allscripts Software as a Medical Device (SaMD) Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Allscripts Software as a Medical Device (SaMD) Product Portfolio Table 84. Allscripts Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Software as a Medical Device (SaMD) Product Image Figure 2. Global Software as a Medical Device (SaMD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Software as a Medical Device (SaMD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Software as a Medical Device (SaMD) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On Premise Image Figure 9. Global Software as a Medical Device (SaMD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Software as a Medical Device (SaMD) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Software as a Medical Device (SaMD) Sales Value Share by Type (2021-2032) Figure 12. Screening and Diagnosis Image Figure 13. Monitoring and Alerting Image Figure 14. Chronic Disease Management Image Figure 15. Other Image Figure 16. Global Software as a Medical Device (SaMD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Software as a Medical Device (SaMD) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Software as a Medical Device (SaMD) Sales Value Share by Application (2021-2032) Figure 19. Global Software as a Medical Device (SaMD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Software as a Medical Device (SaMD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Software as a Medical Device (SaMD) Sales Value (2021-2032) & (US$ Million) Figure 22. North America Software as a Medical Device (SaMD) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Software as a Medical Device (SaMD) Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Software as a Medical Device (SaMD) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Software as a Medical Device (SaMD) Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Software as a Medical Device (SaMD) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Software as a Medical Device (SaMD) Sales Value (2021-2032) & (US$ Million) Figure 28. South America Software as a Medical Device (SaMD) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Software as a Medical Device (SaMD) Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Software as a Medical Device (SaMD) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On Premise
Applications
  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Disease Management
  • Other
Companies covered
  • MindMaze
  • Medtronic
  • Viz.AI.
  • Siemens Healthcare
  • iSchemaView
  • Arterys
  • Adherium
  • Digital Diagnostics
  • Allscripts

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Software as a Medical Device (SaMD) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Software as a Medical Device (SaMD) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Software as a Medical Device (SaMD) Market Dynamics
  1. 2.1 Software as a Medical Device (SaMD) Industry Trends
  2. 2.2 Software as a Medical Device (SaMD) Industry Drivers
  3. 2.3 Software as a Medical Device (SaMD) Industry Opportunities and Challenges
  4. 2.4 Software as a Medical Device (SaMD) Industry Restraints
3 Software as a Medical Device (SaMD) Market by Company
  1. 3.1 Global Software as a Medical Device (SaMD) Company Revenue Ranking in 2025
  2. 3.2 Global Software as a Medical Device (SaMD) Revenue by Company (2021-2026)
  3. 3.3 Global Software as a Medical Device (SaMD) Company Ranking (2024-2026)
  4. 3.4 Global Software as a Medical Device (SaMD) Company Manufacturing Base and Headquarters
  5. 3.5 Global Software as a Medical Device (SaMD) Company Product Type and Application
  6. 3.6 Global Software as a Medical Device (SaMD) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Software as a Medical Device (SaMD) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Software as a Medical Device (SaMD) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Software as a Medical Device (SaMD) Market by Type
  1. 4.1 Software as a Medical Device (SaMD) Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On Premise
  4. 4.2 Global Software as a Medical Device (SaMD) Sales Value by Type
  5. 4.2.1 Global Software as a Medical Device (SaMD) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Software as a Medical Device (SaMD) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Software as a Medical Device (SaMD) Sales Value Share by Type (2021-2032)
5 Software as a Medical Device (SaMD) Market by Application
  1. 5.1 Software as a Medical Device (SaMD) Application Introduction
  2. 5.1.1 Screening and Diagnosis
  3. 5.1.2 Monitoring and Alerting
  4. 5.1.3 Chronic Disease Management
  5. 5.1.4 Other
  6. 5.2 Global Software as a Medical Device (SaMD) Sales Value by Application
  7. 5.2.1 Global Software as a Medical Device (SaMD) Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Software as a Medical Device (SaMD) Sales Value by Application (2021-2032)
  9. 5.2.3 Global Software as a Medical Device (SaMD) Sales Value Share by Application (2021-2032)
6 Software as a Medical Device (SaMD) Regional Value Analysis
  1. 6.1 Global Software as a Medical Device (SaMD) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Software as a Medical Device (SaMD) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Software as a Medical Device (SaMD) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Software as a Medical Device (SaMD) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Software as a Medical Device (SaMD) Sales Value (2021-2032)
  7. 6.3.2 North America Software as a Medical Device (SaMD) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Software as a Medical Device (SaMD) Sales Value (2021-2032)
  10. 6.4.2 Europe Software as a Medical Device (SaMD) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Software as a Medical Device (SaMD) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Software as a Medical Device (SaMD) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Software as a Medical Device (SaMD) Sales Value (2021-2032)
  16. 6.6.2 South America Software as a Medical Device (SaMD) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Software as a Medical Device (SaMD) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Software as a Medical Device (SaMD) Sales Value Share by Country, 2025 VS 2032
7 Software as a Medical Device (SaMD) Country-level Value Analysis
  1. 7.1 Global Software as a Medical Device (SaMD) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Software as a Medical Device (SaMD) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Software as a Medical Device (SaMD) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Software as a Medical Device (SaMD) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Software as a Medical Device (SaMD) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Software as a Medical Device (SaMD) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Software as a Medical Device (SaMD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MindMaze
  2. 8.1.1 MindMaze Company Information
  3. 8.1.2 MindMaze Business Overview
  4. 8.1.3 MindMaze Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MindMaze Software as a Medical Device (SaMD) Product Portfolio
  6. 8.1.5 MindMaze Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Software as a Medical Device (SaMD) Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Viz.AI.
  14. 8.3.1 Viz.AI. Company Information
  15. 8.3.2 Viz.AI. Business Overview
  16. 8.3.3 Viz.AI. Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Viz.AI. Software as a Medical Device (SaMD) Product Portfolio
  18. 8.3.5 Viz.AI. Recent Developments
  19. 8.4 Siemens Healthcare
  20. 8.4.1 Siemens Healthcare Company Information
  21. 8.4.2 Siemens Healthcare Business Overview
  22. 8.4.3 Siemens Healthcare Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Siemens Healthcare Software as a Medical Device (SaMD) Product Portfolio
  24. 8.4.5 Siemens Healthcare Recent Developments
  25. 8.5 iSchemaView
  26. 8.5.1 iSchemaView Company Information
  27. 8.5.2 iSchemaView Business Overview
  28. 8.5.3 iSchemaView Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 iSchemaView Software as a Medical Device (SaMD) Product Portfolio
  30. 8.5.5 iSchemaView Recent Developments
  31. 8.6 Arterys
  32. 8.6.1 Arterys Company Information
  33. 8.6.2 Arterys Business Overview
  34. 8.6.3 Arterys Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Arterys Software as a Medical Device (SaMD) Product Portfolio
  36. 8.6.5 Arterys Recent Developments
  37. 8.7 Adherium
  38. 8.7.1 Adherium Company Information
  39. 8.7.2 Adherium Business Overview
  40. 8.7.3 Adherium Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Adherium Software as a Medical Device (SaMD) Product Portfolio
  42. 8.7.5 Adherium Recent Developments
  43. 8.8 Digital Diagnostics
  44. 8.8.1 Digital Diagnostics Company Information
  45. 8.8.2 Digital Diagnostics Business Overview
  46. 8.8.3 Digital Diagnostics Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Digital Diagnostics Software as a Medical Device (SaMD) Product Portfolio
  48. 8.8.5 Digital Diagnostics Recent Developments
  49. 8.9 Allscripts
  50. 8.9.1 Allscripts Company Information
  51. 8.9.2 Allscripts Business Overview
  52. 8.9.3 Allscripts Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allscripts Software as a Medical Device (SaMD) Product Portfolio
  54. 8.9.5 Allscripts Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst